Corient Private Wealth
ASND icon

Corient Private Wealth’s Ascendis Pharma A/S ASND Stock Holding History

Corient Private Wealth’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$774K Sell
3,383
-3,403
-50% -$763K ﹤0.01% 1789
2025
Q4 		$1.45M Buy
6,786
+3,903
+135% +$806K ﹤0.01% 1693
2025
Q3 		$573K Hold
2,883
– – ﹤0.01% 1721
2025
Q2 		$498K Sell
2,883
-511
-15% -$83.2K ﹤0.01% 1706
2025
Q1 		$529K Buy
3,394
+123
+4% +$17.6K ﹤0.01% 1571
2024
Q4 		$450K Buy
+3,271
New +$430K ﹤0.01% 1679

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return